Reference
Kleijnen S, et al. Relative effectiveness assessments of oncology medicines for pricing and reimbursement decisions in European countries. Annals of Oncology : 20 Jun 2016. Available from: URL: http://doi.org/10.1093/annonc/mdw233
Rights and permissions
About this article
Cite this article
European HTA agencies require robust evidence in oncology. PharmacoEcon Outcomes News 757, 15 (2016). https://doi.org/10.1007/s40274-016-3204-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-016-3204-0